From 15-19 April 2024, a team from WHO headquarters (hqrs) in Geneva, MVPE study Investigators, Feasibility evaluation teams of the evaluation component of Malaria Vaccine Implementation Programme, and statisticians from Ghana, Kenya, Malawi, and the United Kingdom gathered in Accra to finalized analyses and complete four feasibility related manuscripts to be included in the supplement.

The Ghana evaluation team was led by Dr Kwaku Poku Asante the Coordinating Investigator, and Director of Kintampo Health Research Centre of Research and Development Division of Ghana Health Service. Other members of the team consisted of Dr Thomas Gyan MVPE project coordinator for Ghana, Dr Paul Welaga Feasibility project manager, Ms Stephany Gyaase and Dr Elizabeth Awini (study statisticians).

The objectives of the meeting were to:

1. To share updates on publications status, challenges and progress
2. To review, reshape and finalise the feasibility evaluation analyses, cross-country and for each country (Ghana, Kenya, Malawi) separately
3. To draft and finalise tabular and graphical data analyses outputs in publication ready format
4. To complete and finalise initial drafts of four manuscripts:
• Country-specific paper: Baseline site description – Ghana
• Country-specific paper: Baseline site description - Kenya
• Country-specific paper: Baseline site description - Malawi
• Cross-country paper: Factors associated with malaria vaccine uptake during pilot implementation (2019-2023) Ghana, Kenya and Malawi

At end of the five-day writing meeting the following deliverables were completed;

1. Each country team and sub-teams shared current status update of the manuscript, outstanding questions, key indicators and harmonization across the three countries
2. Reviewed the analyses across the countries and agreed on analyses to be included in the main text versus supplement documents
3. Populated table shells, graphs and maps for papers
4. Completed drafts of the papers